• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETBF2513C166E
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Occlusion (1984)
Date of Event 08/14/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Film evaluation summary: the cause of the aaa expansion appears to have been due to the migration of the right limb extension out of the right common iliac artery, which led to the distal type i endoleak.The timing and exact cause of the migration could not be determined.The anatomy at implant is unknown, and earlier post-implant films were not provide for comparison.It is possible that disease progression (iliac artery dilatation) and aneurysm morphology changes (as evidenced by the high limb angulation) may have led to the bilateral limb migration.The cause of the left side stent graft and vessel occlusion could not be determined.The limbs were gradually angulated ~80 deg; however, no stent graft kinks or compression was observed.It is possible that vessel tortuosity or the limb migration out of the lcia may have contributed.The occlusion may also have been caused by a patient condition: poor distal runoff, an unknown coagulopathy that is now presenting, or a previous history of pad.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
An endurant ii stent graft system was implanted in a patient for the endovascular treatment of an unknown size abdominal aortic aneurysm.It was reported that the patient presented emergently approximately two years and nine months later with a type ib endoleak and aneurysm expansion.A secondary procedure was carried out and the stent graft limbs extended bilaterally into the external iliac arteries to resolve the type ib endoleaks.As per film evaluation; the type ib endoleak was on the right ipsi limb and that this side was occluded as far as the bifurcation gate.The limb etlw1624c124e which was extended on the right and has migrated with a type ib endoleak and the contra limb on the left (etlw1620c156e) is 100 % occluded and also may have migrated although there was no endoleak evident.As per the physician, the cause of the event was due to the patient¿s anatomy.There was inadequate seal in the common iliac arteries causing the type ib endoleak.No additional clinical sequelae were reported and the patient is fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key9133528
Report Number9612164-2019-04133
Device Sequence Number11559636
Product Code MIH
UDI-Device Identifier00613994991249
UDI-Public00613994991249
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/13/2018
Device Model NumberETBF2513C166E
Device Catalogue NumberETBF2513C166E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/04/2019
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/04/2019
Initial Report FDA Received Date09/30/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age69 YR
Patient Weight97
-
-